Matthews International (MATW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
15 Jan, 2026Executive summary
Annual meeting scheduled for February 19, 2026, with virtual participation and voting options for shareholders of record as of December 29, 2025.
Major strategic actions in 2025 included divestitures (SGK Brand Solutions, Warehouse Automation), acquisitions, and a focus on deleveraging and shareholder returns.
Board refreshment continued, with five new directors since 2020 and a planned transition of the Chairperson role.
Shareholder engagement and feedback influenced governance enhancements and proposals.
Voting matters and shareholder proposals
Election of four directors to serve until 2027 (or 2029 if declassification is not approved).
Approval of the Second Amended and Restated 2019 Director Fee Plan to increase share pool and align director interests.
Ratification of Ernst & Young LLP as independent auditor for fiscal 2026.
Advisory vote on executive compensation (say-on-pay).
Approval of Amended and Restated Articles of Incorporation, including:
Declassification of the Board over three years (annual elections by 2028).
Adoption of a majority voting standard in uncontested director elections.
Elimination of certain supermajority voting requirements for amendments.
Board of directors and corporate governance
Board consists of 11 members, 10 of whom are independent; five new directors since 2020.
Board committees include Audit, Compensation, Governance and Sustainability, Finance, Executive, and M&A Review.
Board refreshment and diversity prioritized; four of 11 directors are female or diverse.
Independent, non-executive Chairperson role to transition to J. Michael Nauman after the 2026 meeting.
Shareholder rights include single class of common stock, director resignation policy, and robust stock ownership guidelines.
Latest events from Matthews International
- Q1 sales dropped 10.7% to $401.8M; SGK divestiture and Tesla arbitration drive future prospects.MATW
Q1 20259 Jul 2026 - Q2 sales declined 9.3% as SGK deal nears close and cost savings initiatives progress.MATW
Q2 20258 Jul 2026 - Streamlined portfolio, improved margins, and asset sales set leverage to fall below 3.0x.MATW
Q4 20258 Jul 2026 - Memorialization growth and Propelis synergies offset divestiture impacts; EBITDA guidance held.MATW
Q2 20261 May 2026 - Net income $43.6M, sales $284.8M, debt reduced $174M, FY2026 EBITDA guidance $180M.MATW
Q1 20264 Feb 2026 - Q3 sales and earnings fell, but cost cuts and debt reduction efforts are advancing.MATW
Q3 20242 Feb 2026 - Proxy seeks approval for Board declassification, majority voting, and key governance reforms.MATW
Proxy Filing20 Jan 2026 - Settlement with Barington ensures board stability and strategic focus through 2028.MATW
Proxy Filing15 Jan 2026 - Net loss driven by write-downs as sales and adjusted EBITDA declined, but 2025 outlook stable.MATW
Q4 202412 Jan 2026